India's First Integrated Digital Accelerator

REGENXBIO Sectors, Funding and Contact Details

Rockville, Maryland, United States

REGENXBIO

REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Status

Independent

Sectors

• Biopharma • Biotechnology • Genetics • Therapeutics

Employees

Founders

James Brown, James M. Wilson, Kenneth Mills

Last Funding

1/6/2021

Listed/Private

Public

Funding Stage

Post-IPO Equity

Size

Founded

January 1, 2009

Investors

National Institutes of Health, F-Prime Capital, Deerfield, Venrock, Perceptive Advisors

Acquisitions

1

Ticker

RGNX

Study your competition to stay ahead